Mark Ethell

1.6k total citations
44 papers, 952 citations indexed

About

Mark Ethell is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Ethell has authored 44 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 13 papers in Oncology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Ethell's work include Hematopoietic Stem Cell Transplantation (16 papers), Multiple Myeloma Research and Treatments (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Mark Ethell is often cited by papers focused on Hematopoietic Stem Cell Transplantation (16 papers), Multiple Myeloma Research and Treatments (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Mark Ethell collaborates with scholars based in United Kingdom, France and Germany. Mark Ethell's co-authors include Mike Potter, Gareth J. Morgan, Bronwen E. Shaw, Michael Potter, Fiona L. Dignan, Faith E. Davies, H. G. Prentice, Prem Mahendra, J. Paul Seale and Jane Price and has published in prestigious journals such as Blood, British Journal of Haematology and Radiotherapy and Oncology.

In The Last Decade

Mark Ethell

40 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Ethell United Kingdom	17	518	279	218	149	121	44	952
Lidia Gil Poland	17	414 0.8×	413 1.5×	170 0.8×	46 0.3×	80 0.7×	136	1.2k
Luigi Zanesco Italy	21	538 1.0×	267 1.0×	131 0.6×	124 0.8×	143 1.2×	48	1.4k
Prem Mahendra United Kingdom	9	586 1.1×	313 1.1×	64 0.3×	122 0.8×	470 3.9×	14	1.2k
Brigitte Pautard France	15	375 0.7×	138 0.5×	89 0.4×	52 0.3×	163 1.3×	32	791
Okke de Weerdt Netherlands	17	627 1.2×	250 0.9×	393 1.8×	17 0.1×	77 0.6×	49	1.1k
Martin Mohren Germany	17	321 0.6×	188 0.7×	98 0.4×	19 0.1×	136 1.1×	37	936
James N. Butera United States	20	172 0.3×	638 2.3×	129 0.6×	31 0.2×	98 0.8×	55	1.2k
Shmuel Gillis Israel	19	532 1.0×	108 0.4×	88 0.4×	28 0.2×	87 0.7×	44	1.1k
Shakila P. Khan United States	16	664 1.3×	203 0.7×	71 0.3×	25 0.2×	346 2.9×	55	997
Jyh‐Pyng Gau Taiwan	14	277 0.5×	158 0.6×	120 0.6×	26 0.2×	37 0.3×	74	659

Countries citing papers authored by Mark Ethell

Since Specialization

Citations

This map shows the geographic impact of Mark Ethell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ethell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ethell more than expected).

Fields of papers citing papers by Mark Ethell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Ethell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ethell. The network helps show where Mark Ethell may publish in the future.

Co-authorship network of co-authors of Mark Ethell

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Ethell. A scholar is included among the top collaborators of Mark Ethell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Ethell. Mark Ethell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giebel, Sebastian, Myriam Labopin, Mohamed Houhou, et al.. (2023). Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation. 58(4). 393–400. 2 indexed citations

Bagwan, Izhar, et al.. (2022). Tonsillar Extraintestinal Enteropathy-Associated T-Cell Lymphoma in a Patient With Celiac Disease. ACG Case Reports Journal. 9(7). e00824–e00824. 1 indexed citations

Durie, Emily, Emma Nicholson, Chloe Anthias, et al.. (2021). Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique. Radiotherapy and Oncology. 158. 97–103. 7 indexed citations

Shea, Robyn, Mark Ethell, Mike Potter, et al.. (2021). Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 27(10). 880.e1–880.e4. 24 indexed citations

Sriskandarajah, Priya, et al.. (2015). Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients. Thrombosis Journal. 13(1). 21–21. 31 indexed citations

Anthias, Chloe, Mark Ethell, Michael Potter, J. Alejandro Madrigal, & Bronwen E. Shaw. (2014). The impact of improved JACIE standards on the care of related BM and PBSC donors. Bone Marrow Transplantation. 50(2). 244–247. 11 indexed citations

Anoop, Parameswaran, Unell Riley, Mark Ethell, et al.. (2011). First report of fatal human infections with the cactophilic yeast Sporopachydermia cereana. Journal of Infection. 62(4). 311–313. 6 indexed citations

Hiwarkar, Prashant, Bronwen E. Shaw, J. Michael Tredger, et al.. (2010). Mycophenolic acid trough level monitoring: relevance in acute and chronic graft versus host disease and its relation with albumin. Clinical Transplantation. 25(2). 222–227. 16 indexed citations

Anoop, Parameswaran, et al.. (2010). The Feasibility of Plerixafor as a Second-line Stem Cell Mobilizing Agent in Children. Journal of Pediatric Hematology/Oncology. 33(1). 65–67. 20 indexed citations

10.

Wu, Ping, Faith E. Davies, Kevin Boyd, et al.. (2009). The impact of extramedullary disease at presentation on the outcome of myeloma. Leukemia & lymphoma. 50(2). 230–235. 85 indexed citations

11.

Dignan, Fiona L., Stephen O. Evans, Mark Ethell, et al.. (2009). An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. Bone Marrow Transplantation. 44(1). 51–56. 35 indexed citations

12.

Davies, Faith E., Ping Wu, Matthew Jenner, et al.. (2008). Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT‐PACE. European Journal Of Haematology. 81(6). 432–436. 10 indexed citations

13.

Sirohi, Bhawna, R Powles, J Treleaven, et al.. (2008). The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients. Bone Marrow Transplantation. 42(2). 105–112. 11 indexed citations

14.

Dignan, Fiona L., Dorothy M. Gujral, Mark Ethell, et al.. (2007). Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease. Bone Marrow Transplantation. 40(1). 79–82. 59 indexed citations

15.

Dignan, Fiona L., Caroline Alvares, Unell Riley, et al.. (2006). Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality. Journal of Hospital Infection. 63(4). 452–458. 15 indexed citations

16.

Wu, Ping, Faith E. Davies, C Horton, et al.. (2006). The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide – vincristine – doxorubicin – methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis. Leukemia & lymphoma. 47(11). 2335–2338. 33 indexed citations

17.

Alvares, Caroline, Faith E. Davies, C Horton, et al.. (2005). Long‐term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high‐dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments. British Journal of Haematology. 129(5). 607–614. 32 indexed citations

18.

Duarte, Rafael F., Julio Delgado, Bronwen E. Shaw, et al.. (2005). Histologic Features of the Liver Biopsy Predict the Clinical Outcome for Patients with Graft-versus-Host Disease of the Liver. Biology of Blood and Marrow Transplantation. 11(10). 805–813. 19 indexed citations

19.

Madrigal, J. Alejandro, et al.. (2003). Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplantation. 32(10). 1001–1014. 93 indexed citations

20.

Seale, J. Paul, Jane Price, G. Bass, et al.. (1998). Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. British Journal of Haematology. 101(3). 483–486. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact